These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37477758)

  • 1. WTAP Mediates NUPR1 Regulation of LCN2 Through m
    Tan M; He Y; Yi J; Chen J; Guo Q; Liao N; Peng L
    Biochem Genet; 2024 Apr; 62(2):876-891. PubMed ID: 37477758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis.
    Sun G; Wang J; Liu F; Zhao C; Cui S; Wang Z; Liu Z; Zhang Q; Xiang C; Zhang Y; Galons H; Yu P; Teng Y
    Biochem Pharmacol; 2024 Apr; 222():116077. PubMed ID: 38395264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUPR1 is a critical repressor of ferroptosis.
    Liu J; Song X; Kuang F; Zhang Q; Xie Y; Kang R; Kroemer G; Tang D
    Nat Commun; 2021 Jan; 12(1):647. PubMed ID: 33510144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
    Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
    Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POU2F2-mediated upregulation of lncRNA
    Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J
    Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting LCN2 can suppress the development of NSCLC by promoting ferroptosis.
    Pan Z; Li B; Lu P; Rong G; Wang X
    Gene; 2024 Feb; 894():148026. PubMed ID: 38000702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRSF1 inhibits ferroptosis and reduces cisplatin chemosensitivity of triple-negative breast cancer cells through the circSEPT9/GCH1 axis.
    Song X; Wang X; Chen X; Yu Z; Zhou Y
    J Proteomics; 2024 Feb; 292():105055. PubMed ID: 38040194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.
    Chen S; Xia H; Sheng L
    Dig Liver Dis; 2023 Jul; 55(7):967-981. PubMed ID: 36586770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer.
    Qi L; Sun B; Yang B; Lu S
    Breast Cancer Res Treat; 2022 Jun; 193(2):305-318. PubMed ID: 35325342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.
    Valashedi MR; Roushandeh AM; Tomita K; Kuwahara Y; Pourmohammadi-Bejarpasi Z; Kozani PS; Sato T; Roudkenar MH
    Life Sci; 2022 Sep; 304():120704. PubMed ID: 35714703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
    Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
    Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis.
    Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO
    Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
    Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
    J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.
    Cheng G; Sun X; Wang J; Xiao G; Wang X; Fan X; Zu L; Hao M; Qu Q; Mao Y; Xue Y; Wang J
    Cancer Res; 2014 Feb; 74(3):862-72. PubMed ID: 24295734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
    Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS1 acts as a ferroptosis driver to inhibit the progression and chemotherapy resistance of triple-negative breast cancer.
    Wang Y; Pang X; Liu Y; Mu G; Wang Q
    Carcinogenesis; 2023 Dec; 44(8-9):708-715. PubMed ID: 37665951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
    Ding L; Xie Z
    Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.